Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Laura Gutierrez‐Alamillo"'
Autor:
Jemima Albayda, Christopher Mecoli, Livia Casciola‐Rosen, Sonye K. Danoff, Cheng Ting Lin, David Hines, Laura Gutierrez‐Alamillo, Julie J. Paik, Eleni Tiniakou, Andrew L. Mammen, Lisa Christopher‐Stine
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 5, Pp 287-294 (2021)
Objective Antibodies against the small ubiquitin‐like modifier (SUMO) activating enzyme (SAE) are one of the rarer specificities associated with dermatomyositis (DM). The purpose of this study is to describe the clinical characteristics of patients
Externí odkaz:
https://doaj.org/article/e28a870f7a4545ddbb39a9127d21547e
Autor:
Livia Casciola-Rosen, David R. Thiemann, Felipe Andrade, Maria I. Trejo-Zambrano, Elissa K. Leonard, Jamie B. Spangler, Nicole E. Skinner, Justin Bailey, Srinivasan Yegnasubramanian, Rulin Wang, Ajay M. Vaghasia, Anuj Gupta, Andrea L. Cox, Stuart C. Ray, Raleigh M. Linville, Zhaobin Guo, Peter C. Searson, Carolyn E. Machamer, Stephen Desiderio, Lauren M. Sauer, Oliver Laeyendecker, Brian T. Garibaldi, Li Gao, Mahendra Damarla, Paul M. Hassoun, Jody E. Hooper, Christopher A. Mecoli, Lisa Christopher-Stine, Laura Gutierrez-Alamillo, Qingyuan Yang, David Hines, William A. Clarke, Richard E. Rothman, Andrew Pekosz, Katherine Z.J. Fenstermacher, Zitong Wang, Scott L. Zeger, Antony Rosen
Publikováno v:
JCI Insight, Vol 7, Iss 9 (2022)
Background Some clinical features of severe COVID-19 represent blood vessel damage induced by activation of host immune responses initiated by the coronavirus SARS-CoV-2. We hypothesized autoantibodies against angiotensin-converting enzyme 2 (ACE2),
Externí odkaz:
https://doaj.org/article/b514b606a0ee4c42affc7ad2f94c0c67
Autor:
Andrew L. Mammen, Sonye K. Danoff, Eleni Tiniakou, Livia Casciola-Rosen, Jemima Albayda, Laura Gutierrez-Alamillo, Christopher A. Mecoli, David Hines, Julie J. Paik, Lisa Christopher-Stine, Cheng Ting Lin
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 5, Pp 287-294 (2021)
ACR Open Rheumatology
ACR Open Rheumatology
Objective Antibodies against the small ubiquitin-like modifier (SUMO) activating enzyme (SAE) are one of the rarer specificities associated with dermatomyositis (DM). The purpose of this study is to describe the clinical characteristics of patients w
Autor:
Andrew S Koenig, Eleni Tiniakou, Laura Gutierrez-Alamillo, Livia Casciola-Rosen, Liliana Florea, Lisa Christopher-Stine, Sherry G Leung, Grazyna Purwin, Jamie Perin, Julie J. Paik, Corina Antonescu, Jemima Albayda, Joseph Y. Shin, Doris G. Leung
Publikováno v:
Arthritis Rheumatol
Objective This open-label 12-week study was conducted to evaluate the efficacy and safety of tofacitinib, a JAK inhibitor, in treatment-refractory active dermatomyositis (DM). Methods Tofacitinib in extended-release doses of 11 mg was administered da
Autor:
Laura Gutierrez-Alamillo, Matthew Shneyderman, Julie J. Paik, Lisa Christopher-Stine, Andrew S Koenig, Grazyna Purwin, Jemima Albayda, Livia Casciola-Rosen, Sherry Leung, Jamie Perin, Eleni Tiniakou, Doris G. Leung
Publikováno v:
Arthritis Rheumatol
We previously demonstrated that tofacitinib was effective in treating skin-predominant refractory dermatomyositis (DM) at 12 weeks in a prospective open label clinical trial, Study of Tofacitinib In Refractory dermatomyositis (STIR) (1). Here, we rep
Autor:
David R. Thiemann, Andrea L. Cox, Katherine J. Fenstermacher, Richard E. Rothman, Carolyn E. Machamer, Scott L. Zeger, Jody E. Hooper, Elissa K. Leonard, Zitong Wang, William Clarke, Lisa Christopher-Stine, David Hines, Andrew Pekosz, Brian T. Garibaldi, Maria Isabel Trejo Zambrano, Jamie B. Spangler, Livia Casciola-Rosen, Oliver Laeyendecker, Lauren M. Sauer, Christopher A. Mecoli, Stuart C. Ray, Antony Rosen, Qingyuan Yang, Felipe Andrade, Laura Gutierrez-Alamillo
Publikováno v:
medRxiv : the preprint server for health sciences.
SARS-CoV-2 infection induces severe disease in a subpopulation of patients, but the underlying mechanisms remain unclear. We demonstrate robust IgM autoantibodies that recognize angiotensin converting enzyme-2 (ACE2) in 18/66 (27%) patients with seve
Autor:
Tricia R. Cottrell, Marc K. Halushka, Livia Casciola-Rosen, Antony Rosen, Tea Soon Park, Zsuzsanna H. McMahan, Elias T. Zambidis, Fredrick M. Wigley, Laura Gutierrez-Alamillo, Brendan Antiochos, Raffaello Cimbro
Publikováno v:
Arthritis & Rheumatology. 68:2540-2549
Objective Scleroderma patients with autoantibodies to CENPs and/or interferon-inducible protein 16 (IFI-16) are at increased risk of severe vascular complications. This study was undertaken to determine whether these autoantigens are enriched in cell
Autor:
Zsuzsanna H, McMahan, Tricia R, Cottrell, Fredrick M, Wigley, Brendan, Antiochos, Elias T, Zambidis, Tea Soon, Park, Marc K, Halushka, Laura, Gutierrez-Alamillo, Raffaello, Cimbro, Antony, Rosen, Livia, Casciola-Rosen
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.). 68(10)
Scleroderma patients with autoantibodies to CENPs and/or interferon-inducible protein 16 (IFI-16) are at increased risk of severe vascular complications. This study was undertaken to determine whether these autoantigens are enriched in cells of the v